78 related articles for article (PubMed ID: 23681699)
1. Can physician's self-estimates be used as a valid instrument to determine prescription frequencies of anti-psoriatic drugs? Comparison of the results of a cross-sectional study using self-estimates with actual prescription behavior documented in a cohort study.
Nast A; Rosumeck S; Erdmann R; Werner RN
Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1154-8. PubMed ID: 23681699
[TBL] [Abstract][Full Text] [Related]
2. Do guidelines change the way we treat? Studying prescription behaviour among private practitioners before and after the publication of the German Psoriasis Guidelines.
Nast A; Erdmann R; Hofelich V; Reytan N; Orawa H; Sterry W; Rzany B
Arch Dermatol Res; 2009 Sep; 301(8):553-9. PubMed ID: 19609542
[TBL] [Abstract][Full Text] [Related]
3. Drug supply for children with psoriasis in Germany.
Augustin M; Reich K; Glaeske G; Kämpfe S; Radtke MA; Gerdau-Heitmann C; Schicktanz C; Schäfer I
J Dtsch Dermatol Ges; 2013 Aug; 11(8):751-5. PubMed ID: 23718227
[TBL] [Abstract][Full Text] [Related]
4. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
Sneed RC; May WL; Stencel C
Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
[TBL] [Abstract][Full Text] [Related]
5. Processes of psoriasis health care in Germany--long-term analysis of data from the statutory health insurances.
Augustin M; Glaeske G; Schäfer I; Rustenbach SJ; Hoer A; Radtke MA
J Dtsch Dermatol Ges; 2012 Sep; 10(9):648-55. PubMed ID: 22525221
[TBL] [Abstract][Full Text] [Related]
6. Patterns of vitamin D analog use for the treatment of psoriasis.
Ahn CS; Awadalla F; Huang KE; Yentzer B; Dabade TS; Feldman SR
J Drugs Dermatol; 2013 Aug; 12(8):906-10. PubMed ID: 23986164
[TBL] [Abstract][Full Text] [Related]
7. Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry.
Nast A; Reytan N; Rosumeck S; Erdmann R; Rzany B
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1337-42. PubMed ID: 18624864
[TBL] [Abstract][Full Text] [Related]
8. How do regional factors influence psoriasis patient care in Germany?
Radtke MA; Augustin J; Blome C; Reich K; Rustenbach SJ; Schäfer I; Laass A; Augustin M
J Dtsch Dermatol Ges; 2010 Jul; 8(7):516-24. PubMed ID: 20163501
[TBL] [Abstract][Full Text] [Related]
9. Quality of psoriasis care in Germany--results of the national study PsoHealth 2007.
Augustin M; Reich K; Reich C; Purwins S; Jeff Rustenbach S; Schäfer I; Radtke M
J Dtsch Dermatol Ges; 2008 Aug; 6(8):640-5. PubMed ID: 18801145
[TBL] [Abstract][Full Text] [Related]
10. Differing patterns of methotrexate use for psoriatic disease among dermatologists and rheumatologists.
Dupuis EC; Bhole VM; Dutz JP
Br J Dermatol; 2012 Aug; 167(2):448-50. PubMed ID: 22309601
[No Abstract] [Full Text] [Related]
11. Factors affecting prescription of ultra-high potency topical corticosteroids in skin disease: an analysis of US national practice data.
Balkrishnan R; Camacho FT; Pearce DJ; Kulkarni AS; Spencer L; Fleischer AB; Feldman SR
J Drugs Dermatol; 2005; 4(6):699-706. PubMed ID: 16302555
[TBL] [Abstract][Full Text] [Related]
12. Considerable variation among Iranian dermatologists in the dosing and monitoring of methotrexate for treating psoriasis.
Zargari O; Hejazi S; Shahidi-Dadras M; Younespour S; Robati R; Firooz A; Toosi P; Feldman SR
Int J Dermatol; 2014 Mar; 53(3):385-9. PubMed ID: 24134730
[TBL] [Abstract][Full Text] [Related]
13. Pattern of prescriptions issued by nursing home-based physicians versus office-based physicians for frail elderly patients in German nursing homes.
Pittrow D; Krappweis J; Rentsch A; Schindler C; Hach I; Bramlage P; Kirch W
Pharmacoepidemiol Drug Saf; 2003; 12(7):595-9. PubMed ID: 14558183
[TBL] [Abstract][Full Text] [Related]
14. Trends in older adult psoriasis outpatient health care practices in the United States.
Wong JW; Davis SA; Feldman SR; Koo JY
J Drugs Dermatol; 2012 Aug; 11(8):957-62. PubMed ID: 22859241
[TBL] [Abstract][Full Text] [Related]
15. Translating psoriasis treatment guidelines into clinical practice - the need for educational interventions and strategies for broad dissemination.
Nast A; Erdmann R; Pathirana D; Rzany B
J Eval Clin Pract; 2008 Oct; 14(5):803-6. PubMed ID: 19018914
[TBL] [Abstract][Full Text] [Related]
16. Evidence-based (S3) guidelines for the treatment of psoriasis vulgaris.
Nast A; Kopp IB; Augustin M; Banditt KB; Boehncke WH; Follmann M; Friedrich M; Huber M; Kahl C; Klaus J; Koza J; Kreiselmaier I; Mohr J; Mrowietz U; Ockenfels HM; Orzechowski HD; Prinz J; Reich K; Rosenbach T; Rosumeck S; Schlaeger M; Schmid-Ott G; Sebastian M; Streit V; Weberschock T; Rzany B; ;
J Dtsch Dermatol Ges; 2007 Jul; 5 Suppl 3():1-119. PubMed ID: 17615051
[TBL] [Abstract][Full Text] [Related]
17. Prescriber response to unsolicited prescription drug monitoring program reports in Massachusetts.
Thomas CP; Kim M; Nikitin RV; Kreiner P; Clark TW; Carrow GM
Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):950-7. PubMed ID: 24920376
[TBL] [Abstract][Full Text] [Related]
18. Patient benefit index (PBI) in the treatment of psoriasis--results of the National Care Study "PsoHealth".
Radtke MA; Schäfer I; Blome C; Augustin M
Eur J Dermatol; 2013 Apr; 23(2):212-7. PubMed ID: 23587940
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy for psoriasis in the United States.
Davis SA; Feldman SR
J Drugs Dermatol; 2013 May; 12(5):546-50. PubMed ID: 23652949
[TBL] [Abstract][Full Text] [Related]
20. [Assessment off-label prescribing in Dermatology].
Picard D; Carvalho P; Bonnavia C; Louin L; Josset V; Lauret P; Joly P;
Ann Dermatol Venereol; 2003 May; 130(5):507-10. PubMed ID: 12843825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
